Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Gastrointestinal side effects like constipation rank among the most common challenges when starting semaglutide therapy, with clinical trials showing delayed bowel movements in roughly one-quarter of patients during early treatment phases. Understanding how to manage this symptom safely and effectively helps many people continue their weight loss journey without interruption. PlexusDx provides evidence-based guidance to help you find relief while maintaining your GLP-1 treatment plan.
How GLP-1 Medications Slow Digestion
Semaglutide works by slowing gastric emptying—the rate at which food leaves your stomach and enters your small intestine. This mechanism helps you feel fuller longer and eat smaller portions, which drives weight loss. However, this same slowing effect can lead to reduced bowel movement frequency, especially in the first two to four weeks of therapy.
The drug also activates receptors in your digestive tract that signal satiety to your brain. While this is beneficial for appetite control, it can temporarily reduce the natural contractions (peristalsis) that move stool through your colon. Most patients adapt within 4-8 weeks as their body adjusts to the medication, though some experience ongoing constipation that requires active management.
Hydration and Fiber: First-Line Prevention Strategies
Increasing water intake is the single most effective non-pharmaceutical approach to GLP-1 constipation. Most clinicians recommend drinking at least 2.5-3 liters (about 80-100 ounces) of water daily when taking semaglutide, roughly 30% more than standard recommendations. Proper hydration softens stool and provides the fluid your colon needs to move waste efficiently.
Adding soluble fiber gradually can also help restore regular bowel function without causing bloating or gas. Focus on sources like oats, psyllium husk, ground flaxseed, and legumes, increasing intake slowly over one to two weeks. Combine higher fiber intake with your increased water consumption—fiber without adequate hydration can actually worsen constipation. Aim for 25-35 grams of total fiber daily, but add it incrementally to allow your digestive system to adjust.
Over-the-Counter and Prescription Relief Options
Osmotic laxatives like polyethylene glycol (MiraLAX) or magnesium citrate work by drawing water into your intestines, softening stool and increasing bowel frequency. These are gentler than stimulant laxatives and can be used regularly without forming dependence. Most GLP-1 patients find these effective when combined with hydration and fiber increases.
Stool softeners such as docusate (Colace) ease passage by reducing surface tension and allowing water to mix more readily with stool. Some patients benefit from combination approaches: a stool softener plus a fiber supplement plus adequate water creates a multi-pronged strategy. If constipation persists beyond two weeks despite these measures, contact your PlexusDx provider—occasional prescription options like lactulose or low-dose naloxone may be appropriate.
Lifestyle and Dietary Adjustments for Better Digestion
Movement and exercise stimulate intestinal contractions naturally. Even 15-20 minutes of walking after meals can activate your digestive system and encourage regular bowel movements. Consistency matters more than intensity—daily moderate activity outperforms occasional intense workouts for digestive regularity.
Meal timing and composition also influence bowel function on GLP-1 therapy. Eating smaller, more frequent meals rather than three large ones can reduce the digestive burden and support more consistent gut motility. Include adequate protein and fat at each meal to maintain satiety, but balance these with vegetables and whole grains that provide natural fiber. Limiting processed foods, excess sugar, and high-fat snacks—which slow digestion further—can make a meaningful difference in constipation severity.
When to Speak with Your Provider About Dose or Medication Changes
Mild constipation that responds to hydration, fiber, and lifestyle changes typically resolves on its own within 4-8 weeks and does not require dose adjustments. However, if constipation is severe, persistent, or interferes with your quality of life after two weeks of consistent management efforts, notify your PlexusDx care team. Your provider may temporarily pause dose increases, extend the interval between injections, or explore alternative formulations.
PlexusDx offers both semaglutide injection (starting at $149/month) and oral semaglutide options; some patients find one formulation produces less constipation than another. Your dose may need to go up as your body adapts and you progress toward your therapeutic target, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose level. If constipation severely limits your ability to continue treatment, your provider can discuss whether a medication switch or genetic testing through the Precision Peptide Genetic Test might identify alternative pathways better suited to your individual biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long does constipation last when starting semaglutide?
Most patients experience constipation most intensely during the first two to four weeks of treatment, with symptoms improving significantly by week 6-8 as the body adjusts. Some individuals continue to have mild constipation throughout their treatment and manage it successfully with hydration, fiber, and laxative support. If constipation persists beyond eight weeks despite active management, contact your PlexusDx provider to discuss dose timing or formulation options.
Can I use a stimulant laxative like senna while on semaglutide?
Stimulant laxatives can be used occasionally for acute constipation but are not ideal for daily, long-term use because they may cause dependence and electrolyte imbalances. Osmotic laxatives and stool softeners are safer for regular use alongside GLP-1 therapy. If you need daily laxative support beyond two weeks, consult your PlexusDx provider about whether your dose schedule or medication type should be adjusted.
Does the Precision Peptide Genetic Test predict my risk for GLP-1 constipation?
The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights related to peptide signaling and metabolism, including variants in GLP1R and MC4R that influence digestive function. While the test does not directly predict constipation risk, it can identify which compounds and pathway combinations may work best for your individual genetics, potentially reducing overall side effects. The test is available as a $99 add-on after your first month of treatment with PlexusDx.
Is constipation a sign that semaglutide is working?
Constipation is a common side effect of semaglutide but is not a necessary sign of efficacy—many patients lose weight without significant constipation. Semaglutide works by reducing hunger and slowing stomach emptying; constipation is an unintended consequence of the latter effect, not proof the medication is working. Focus on weight loss and appetite reduction as true indicators of therapeutic success; manage constipation as a separate concern.
Why is PlexusDx semaglutide injection a good option for GLP-1 constipation?
PlexusDx semaglutide injection (starting at $149/month) is compounded by licensed 503A pharmacies and offers flexible dosing—your dose may increase as you progress, but your price stays the same. If you experience significant constipation with injections, PlexusDx also offers oral semaglutide as an alternative, sometimes associated with slightly different side effect profiles. Your provider can help you choose the formulation and dose schedule that minimizes constipation while maximizing your weight loss results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Do I Put the Ozempic Shot: A Guide to Injection Sites
Beyond Weight Loss: How Does Wegovy Help Heart Health and Cardiovascular Wellness?